People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Biotechnology, Pharmaceuticals, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dataminr, Inc. | — | Other Technology | Series D+ | $911.6M | $10.4B | 2013 |
| Alder Biopharmaceuticals Inc | — | Biotechnology | Series C | $100.0M | $4.1B | 2018 |
| Limerick Biopharma Inc | — | Pharmaceuticals | Series B | $52.8M | $16.3M | 2009 |
| Signal Financial Technologies Inc. | — | Software / Tech | Seed | $12.7M | $21.0M | 2020 |
Stephen Dow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Dow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kristina Burow | 1 | 16 |
| Corey Goodman | 1 | 13 |
| Chad Waite | 1 | 11 |
| Nick Beim | 1 | 8 |
| Steve Dow | 1 | 7 |
| Scott Minick | 1 | 7 |
| Daniel O'Connor | 1 | 5 |
| Paul Carter | 1 | 4 |
| Corey S. Goodman | 1 | 4 |
| Wendye Robbins | 1 | 3 |
| Alan Bruce Montgomery | 1 | 3 |
| John Cooley | 1 | 2 |
| Edward Bailey | 1 | 2 |
| Samuel Hendel | 1 | 2 |
| Stephen Ross | 1 | 2 |
| Sean Collins | 1 | 2 |
| Heather Bruce Preston | 1 | 2 |
| Mark James Litton | 1 | 2 |
| Randall Schatzman | 1 | 2 |
| Ving Lee | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.